NASDAQ: SLNO - Soleno Therapeutics, Inc.

Altı ay boyunca karlılık: +42.58%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Soleno Therapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2014-11-13
ISIN US8342033094
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://soleno.life
Цена ао 48.97
Günlük fiyat değişimi: +6.83% (67.39)
Haftalık fiyat değişimi: +46.59% (49.11)
Aylık fiyat değişimi: +59.62% (45.1)
3 ayda fiyat değişimi: +60.62% (44.82)
Altı ayda fiyat değişimi: +42.58% (50.49)
Yıllık fiyat değişimi: +68.2% (42.8)
3 yılda fiyat değişimi: +24 444.83% (0.2933)
5 yılda fiyat değişimi: +2 498.92% (2.77)
Yılbaşından bu yana fiyat değişimi: +52.96% (47.065)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 7.43 1
P/E 0 0
EV/EBITDA -12.41 0
Toplam: 1.38

Yeterlik

İsim Anlam Seviye
ROA, % -68.74 0
ROE, % -87.35 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0817 10
Toplam: 9.2

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -51866.73 0
karlılık Ebitda, % 132.89 10
karlılık EPS, % 18.94 3
Toplam: 6.6
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Vivo Capital, LLC 8418093 25.93
Nantahala Capital Management, LLC 5712702 17.6
Perceptive Advisors LLC 3074542 9.47
Carlyle Group Inc. 2857804 8.8
Janus Henderson Group PLC 2523897 7.78
Adage Capital Partners GP L.L.C. 1826814 5.63
Vestal Point Capital, LP 1300000 4
Vanguard Group Inc 969622 2.99
Balyasny Asset Management LLC 926876 2.86
Avoro Capital Advisors LLC 785000 2.42

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
iShares Russell 2000 Growth ETF 0.08818 38.04 0.6026
iShares ESG Aware MSCI USA Small-Cap ETF 0.04862 18.09 1.49366
iShares Morningstar Small-Cap Growth ETF 0.04077 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.04077 33.63 0.72598
iShares Morningstar Small-Cap ETF 0.02055 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.02055 30.1 1.60498
iShares Russell 3000 ETF 0.00204 24.83 1.43482
0.04160.551.17



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Anish Bhatnagar M.D. President, CEO, COO & Director 1.06M 1970 (55 yıllar)
Mr. James H. MacKaness Chief Financial Officer 640k 1964 (61 yıl)
Dr. Neil M. Cowen M.B.A., Ph.D. Senior Vice President of Drug Development N/A
Ms. Kristen Yen M.S. Senior Vice President of Clinical Operations 317.19k 1969 (56 yıllar)
Ms. Meredith Manning M.B.A. Chief Commercial Officer N/A 1972 (53 yıl)
Ms. Patricia C. Hirano M.P.H. Senior Vice President of Regulatory Affairs 493k 1966 (59 yıllar)
Ms. Lauren Budesheim Vice President of People N/A
Dr. Michael Huang M.D. Senior Vice President of Clinical Development N/A 1974 (51 yıl)
Dr. Raymond W. Urbanski M.D., Ph.D. Chief Development Officer 1959 (66 yıllar)

Adres: United States, Redwood City. CA, 203 Redwood Shores Parkway - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://soleno.life